These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 15707697)

  • 1. Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease.
    Choi HJ; Lee SY; Cho Y; Hwang O
    Neurochem Int; 2005 Mar; 46(4):329-35. PubMed ID: 15707697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine-dependent cytotoxicity of tetrahydrobiopterin: a possible mechanism for selective neurodegeneration in Parkinson's disease.
    Choi HJ; Kim SW; Lee SY; Hwang O
    J Neurochem; 2003 Jul; 86(1):143-52. PubMed ID: 12807434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes.
    Lim JH; Kim SS; Boo DH; No H; Kang BY; Kim EM; Hwang O; Choi HJ
    Neurosci Lett; 2009 Feb; 451(3):185-9. PubMed ID: 19146917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydrobiopterin causes mitochondrial dysfunction in dopaminergic cells: implications for Parkinson's disease.
    Choi HJ; Lee SY; Cho Y; No H; Kim SW; Hwang O
    Neurochem Int; 2006 Mar; 48(4):255-62. PubMed ID: 16343695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system.
    Kim ST; Choi JH; Chang JW; Kim SW; Hwang O
    J Neurochem; 2005 Oct; 95(1):89-98. PubMed ID: 16181415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of apoptosis and calcium mobilization in tetrahydrobiopterin-induced dopaminergic cell death.
    Choi HJ; Kim SW; Lee SY; Moon YW; Hwang O
    Exp Neurol; 2003 Jun; 181(2):281-90. PubMed ID: 12782000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
    Sajadi A; Bauer M; Thöny B; Aebischer P
    J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
    Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
    Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrahydrobiopterin is released from and causes preferential death of catecholaminergic cells by oxidative stress.
    Choi HJ; Jang YJ; Kim HJ; Hwang O
    Mol Pharmacol; 2000 Sep; 58(3):633-40. PubMed ID: 10953058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.
    Masoud ST; Vecchio LM; Bergeron Y; Hossain MM; Nguyen LT; Bermejo MK; Kile B; Sotnikova TD; Siesser WB; Gainetdinov RR; Wightman RM; Caron MG; Richardson JR; Miller GW; Ramsey AJ; Cyr M; Salahpour A
    Neurobiol Dis; 2015 Feb; 74():66-75. PubMed ID: 25447236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCB-induced inhibition of the vesicular monoamine transporter predicts reductions in synaptosomal dopamine content.
    Bemis JC; Seegal RF
    Toxicol Sci; 2004 Aug; 80(2):288-95. PubMed ID: 15115888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons.
    German DC; Liang CL; Manaye KF; Lane K; Sonsalla PK
    Neuroscience; 2000; 101(4):1063-9. PubMed ID: 11113355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
    González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M
    J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6R-Tetrahydrobiopterin induces dopamine synthesis in a human neuroblastoma cell line, LA-N-1. A cellular model of DOPA-responsive dystonia.
    Zuddas A; Mancosu C; Lilliu V; Sorrentino G; di Porzio U; Cianchetti C
    Brain Res; 2002 Jul; 943(2):257-62. PubMed ID: 12101048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation.
    Asanuma M; Miyazaki I; Diaz-Corrales FJ; Miyoshi K; Ogawa N; Murata M
    Neurosci Res; 2008 Jan; 60(1):106-13. PubMed ID: 18022268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline Rescues from Zinc-Induced Nigrostriatal Dopaminergic Neurodegeneration: Biochemical and Molecular Interventions.
    Kumar V; Singh BK; Chauhan AK; Singh D; Patel DK; Singh C
    Mol Neurobiol; 2016 Jul; 53(5):2761-2777. PubMed ID: 25764516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132.
    Zafar KS; Inayat-Hussain SH; Ross D
    J Neurochem; 2007 Aug; 102(3):913-21. PubMed ID: 17504267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels.
    Vergo S; Johansen JL; Leist M; Lotharius J
    Brain Res; 2007 Dec; 1185():18-32. PubMed ID: 18028884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.
    Paris I; Martinez-Alvarado P; Perez-Pastene C; Vieira MN; Olea-Azar C; Raisman-Vozari R; Cardenas S; Graumann R; Caviedes P; Segura-Aguilar J
    J Neurochem; 2005 Mar; 92(5):1021-32. PubMed ID: 15715653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.